There are 2185 resources available
67O - Polygenic risk score associations with immune checkpoint inhibitors related endocrine toxicity
Presenter: Christian Thorball
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Abstract
1206MO - ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK+ non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)
Presenter: Ben Solomon
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Abstract
1142O - Multivariable analysis of streptozotocin plus 5-fluorouracil and everolimus sequences in advanced pancreatic neuroendocrine tumor patients: The SEQTOR trial (GETNE-1206)
Presenter: Ramon Salazar Soler
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Abstract
1719O - Multisarc: A randomized precision medicine study in advanced soft-tissue sarcomas
Presenter: Benjamin Verret
Session: Proffered paper session: Sarcoma
Resources:
Abstract
1541MO - Leadership roles in oncology: Gender is still a barrier. Results from the new ESMO Women for Oncology Committee authorship and monitoring studies
Presenter: Helena Linardou
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
1207MO - Neoadjuvant nivolumab monotherapy for high-risk clinical stage I non-small cell lung cancer: A phase II POTENTIAL study
Presenter: Yasuhiro Tsutani
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Abstract
1542MO - Mapping the scale of off-label use in oncology: An important step in harmonising access
Presenter: Hans Timmer
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
68O - Frequency of clinical acquired RAS-MAPK pathway resistance alterations in patients treated with KRASG12C inhibitors: An individual patient meta-analysis
Presenter: Jakob Riedl
Session: Proffered paper session 2: Basic science & Translational research
Resources:
Abstract
1208MO - Phase III trial of perioperative pirfenidone therapy for lung cancer with idiopathic pulmonary fibrosis (IPF): NEJ034 study
Presenter: Yukinobu Goto
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Abstract
1143O - Refining molecular classification of neuroendocrine tumors from diverse origins using multi-omic integration models: Unveiling novel neuroendocrine subtypes and their clinical implications
Presenter: Carlos Carretero-Puche
Session: Proffered paper session: NETs and endocrine tumours
Resources:
Abstract